https://www.selleckchem.com/pr....oducts/iberdomide.ht
Our results support the investigation of ld-IL2 in MDS associated with immune disorders in controlled clinical studies. To assess the effect of rituximab (RTX) on the lung function parameters in SSc interstitial lung disease (SSc-ILD) patients. PubMed and Embase were searched to identify studies on SSc-ILD treated with RTX, confined to a predefined inclusion and exclusion criteria. A systematic review and meta-analysis were performed on the included studies on changes in forced vital capacity (FVC) and diffusion capacity of carbon mo
Like
Comment
Share
